Latest News - #Sergey Chemezov

Rostec presented a new screening system on the basis of KAMAZ

Rostec presented to the Ministry of transport of the Russian Federation and Federal customs service new individual screening complex (IDK) on the chassis of KAMAZ, the correspondent of RIA Novosti.

The event was attended by the CEO of Rodeja Sergey Chemezov, Minister of transport Eugene Dietrich and Director of the FCS Vladimir Bulavin. During the presentation, rostec and the Ministry of transport signed a cooperation agreement.

Russia is considering the supply of Turkey the second batch of s-400

Russia was working to supply the second batch of air defense systems s-400, Turkey. About this informed the head of "Rosteh" Sergey Chemezov at a meeting with President Vladimir Putin.

The head of state Corporation has told about the early performance of a contract for the supply of Turkey systems s-400. Chemezov noted that this is the first deal of this scale with a country-a NATO member — the amount of the contract amounted to $ 2.5 billion.

In "Rostec" told what weapons are most in demand abroad

Military-technical cooperation "Rostec" the main demand abroad can be traced to the production of the air force and air defense, said at a meeting with Vladimir Putin the General Director of state Corporation Sergey Chemezov.

"The portfolio of orders has remained at a level of 2018 is 51.1 billion us dollars – a large package, and the memory we have stored the third year. Although we do it, but at the same time, signed again," he said, speaking of the results in 2019.

Rostec and RDIF will start to produce medication for the treatment of coronavirus

Holding "national immunobiological company" the state Corporation "rostec" and the Russian direct investment Fund (RDIF) will begin to release drug based on blood plasma for the treatment of COVID-19, production is scheduled to deploy immediately on four grounds stated in the joint message of the companies.

"The partnership between RDIF and holding "national immunobiological company" involves the production of an immunoglobulin preparation that contains antibodies to the coronavirus SARS CoV-2. It will be made on the basis of plasma donors who have had coronavirus infection", - stated in the message.